Inflazyme Pharmaceuticals (T.IZP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Culver who wrote (836)	2/24/1998 1:40:00 PM
From: Harold Lehman	Read Replies (2) of 1501

Dave, I did some calling around and found some info regarding the anticancer agents with which Inflazyme is joint venturing with Supergen (the agreement was signed last April). I spoke with Supergen's Executive Vice President, Dr. Raj Shrotrya, who was very enthusiastic about the potential of Inflazyme's compounds. He said that they were VERY interesting and said it with fervor. What has been going on is that IZP supplied Supergen with a small amount of a compound, which they tested. They needed more, which was given to them last week. Why the delay? The compound was originally produced by bacteria grown in an agar. It cannot be bulk produced by this method and required the development of a batch fermentative process in a liquid growth media (agar is solid for those who don't remember any biology). It took awhile to find an effective media and then produce much larger amounts. Inflazyme is now looking for a CRO to take over production, with the associated quality assurance. I am feeling fairly upbeat because it looks like there has been steady progress with a diverse stream of products. HL

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next